| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
,||
*
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore MD, 21205;
Immunology Graduate Program and Department of Otolaryngology/Head and Neck Surgery, Johns Hopkins Medical Institutions, Baltimore, MD 21205;
AIDS Research Service and Infectious Disease Unit, Massachusetts General Hospital and Harvard Medical School, Charlestown, MA 02129;
§
Department of Microbiology and Immunology, Emory University School of Medicine, Atlanta, GA 30329;
¶
Department of Medicine, Division of Infectious Diseases, University of Texas Southwestern Medical School, Dallas, TX 75235; and
||
New England Primate Research Center, Harvard Medical School, Southborough, MA 01772
Processing of viral proteins for recognition by CTL involves degradation of the proteins in the cytosol of an infected cell followed by transport of the resulting peptides into the endoplasmic reticulum (ER) by the TAP1/2 complex. Uncertainty exists over the site of processing of viral envelope (env) proteins since the extracellular domains of env proteins are not present in the cytosol where the class I Ag-processing pathway begins. Rather, the ectodomains of env proteins are cotranslationally translocated into the ER during biosynthesis. To analyze env protein processing, we used the herpes simplex virus protein ICP47 to block peptide transport by TAP1/2 and examined the effects of TAP blockade on the processing of the HIV-1 env protein. For the majority of env-specific CD8+ CTL, the processing pathway required TAP1/2-mediated transport of cytosolic peptides into the ER. To determine how env peptides are generated in the cytosol, we analyzed the processing of two TAP1/2-dependent epitopes containing N-linked glycosylation sites. In each case, processing involved glycosylation-dependent posttranslational modification of asparagine residues to aspartic acid. These results are consistent with cotranslational translocation of env into the ER, where glycosylation occurs. This is followed by export of a fraction of the newly synthesized protein into the cytosol, where it is deglycosylated, with conversion of the asparagines to aspartic acid residues. Following cytoplasmic proteolysis, env peptides are retransported by TAP1/2 into the ER, where association with class I occurs. Thus, the env protein can enter the class I pathway through multiple distinct processing mechanisms.
This article has been cited by other articles:
|
|
 |
|
  H. Chen, A. Piechocka-Trocha, T. Miura, M. A. Brockman, B. D. Julg, B. M. Baker, A. C. Rothchild, B. L. Block, A. Schneidewind, T. Koibuchi, et al. Differential Neutralization of Human Immunodeficiency Virus (HIV) Replication in Autologous CD4 T Cells by HIV-Specific Cytotoxic T Lymphocytes J. Virol., April 1, 2009; 83(7): 3138 - 3149. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. L. Altrich-VanLith, M. Ostankovitch, J. M. Polefrone, C. A. Mosse, J. Shabanowitz, D. F. Hunt, and V. H. Engelhard Processing of a Class I-Restricted Epitope from Tyrosinase Requires Peptide N-Glycanase and the Cooperative Action of Endoplasmic Reticulum Aminopeptidase 1 and Cytosolic Proteases J. Immunol., October 15, 2006; 177(8): 5440 - 5450. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Zhang, B. Gaschen, W. Blay, B. Foley, N. Haigwood, C. Kuiken, and B. Korber Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin Glycobiology, December 1, 2004; 14(12): 1229 - 1246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Xu, S. J. Gendler, and A. Franco Designer Glycopeptides for Cytotoxic T Cell-based Elimination of Carcinomas J. Exp. Med., March 1, 2004; 199(5): 707 - 716. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. P. Nayak, G. Sailaja, and A. M. Jabbar Enhancement of gp120-Specific Immune Responses by Genetic Vaccination with the Human Immunodeficiency Virus Type 1 Envelope Gene Fused to the Gene Coding for Soluble CTLA4 J. Virol., October 15, 2003; 77(20): 10850 - 10861. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Sailaja, S. Husain, B. P. Nayak, and A. M. Jabbar Long-Term Maintenance of gp120-Specific Immune Responses by Genetic Vaccination with the HIV-1 Envelope Genes Linked to the Gene Encoding Flt-3 Ligand J. Immunol., March 1, 2003; 170(5): 2496 - 2507. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. N. Golovina, E. J. Wherry, T. N. J. Bullock, and L. C. Eisenlohr Efficient and Qualitatively Distinct MHC Class I-Restricted Presentation of Antigen Targeted to the Endoplasmic Reticulum J. Immunol., March 15, 2002; 168(6): 2667 - 2675. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Lautscham, S. Mayrhofer, G. Taylor, T. Haigh, A. Leese, A. Rickinson, and N. Blake Processing of a Multiple Membrane Spanning Epstein-Barr Virus Protein for Cd8+T Cell Recognition Reveals a Proteasome-Dependent, Transporter Associated with Antigen Processing-Independent Pathway J. Exp. Med., October 15, 2001; 194(8): 1053 - 1068. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Bai, C. J. Aldrich, and J. Forman Factors Controlling the Trafficking and Processing of a Leader-Derived Peptide Presented by Qa-1 J. Immunol., December 15, 2000; 165(12): 7025 - 7034. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hudrisier, J. Riond, H. Mazarguil, M. B. A. Oldstone, and J. E. Gairin Genetically Encoded and Post-translationally Modified Forms of a Major Histocompatibility Complex Class I-restricted Antigen Bearing a Glycosylation Motif Are Independently Processed and Co-presented to Cytotoxic T Lymphocytes J. Biol. Chem., December 17, 1999; 274(51): 36274 - 36280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. C. F. Mulder and M. A. Muesing Degradation of HIV-1 Integrase by the N-end Rule Pathway J. Biol. Chem., September 15, 2000; 275(38): 29749 - 29753. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
